Apigenin is a naturally occurring flavonoid most commonly found in chamomile (Matricaria chamomilla), a plant long recognised for its traditional use in supporting calm and balance within the body. More recently, scientific interest has explored apigenin’s interaction with pathways involved in relaxation, oxidative stress, and healthy ageing processes.
However, apigenin in its isolated form presents a key challenge, it is poorly absorbed and rapidly metabolised, which can limit its effectiveness when delivered through conventional supplementation.
APIMILE™ Bioactive has been developed to address this. It combines a standardised dose of apigenin with organic chamomile extract, allowing for both the targeted compound and the broader plant matrix of naturally occurring bioactives. This reflects the Natroceutics approach of working with both nature and science, rather than isolating one from the other.
To further support absorption, the formulation is delivered using liposomal technology. This means the active compounds are encapsulated in a lipid layer, helping protect them through digestion and supporting more consistent uptake in the body.
The result is a considered, once-daily formulation designed to deliver chamomile and apigenin in a form that prioritises bioavailability, consistency, and ease of use — aligned with the Natroceutics standard of real-world efficacy and scientifically supported formulations
